These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8212987)

  • 1. Lipoprotein(a) and postmenopausal oestrogen.
    Farish E; Rolton HA; Barnes JF; Fletcher CD; Walsh DJ; Spowart KJ; Hart DM
    Acta Endocrinol (Copenh); 1993 Sep; 129(3):225-8. PubMed ID: 8212987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of plasma low density lipoprotein subfractions to oestrogen replacement therapy following surgical menopause.
    Griffin B; Farish E; Walsh D; Barnes J; Caslake M; Shepherd J; Hart D
    Clin Endocrinol (Oxf); 1993 Oct; 39(4):463-8. PubMed ID: 8287573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the metabolic tolerance in postmenopausal women over a 1-year period of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone.
    Meuwissen JH; Beijers-De Bie L; Vihtamaki T; Tuimala R; Siseles N; Magaril C; The HS; Houben PW; Murga M; Spielmann D; De Villiers TJ
    Gynecol Endocrinol; 2002 Apr; 16(2):155-62. PubMed ID: 12012627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
    Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel intermittent regimen of norgestimate to preserve the beneficial effects of 17beta-estradiol on lipid and lipoprotein profiles.
    Lobo RA; Zacur HZ; Caubel P; Lane R
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):41-9. PubMed ID: 10649155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined oestrogen-progestin replacement therapy prevents atherosclerosis in postmenopausal women.
    Punnonen RH; Jokela HA; Dastidar PS; Nevala M; Laippala PJ
    Maturitas; 1995 Apr; 21(3):179-87. PubMed ID: 7616866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study.
    Perera M; Sattar N; Petrie JR; Hillier C; Small M; Connell JM; Lowe GD; Lumsden MA
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1140-3. PubMed ID: 11238498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral estradiol on Lp(a) and other lipoproteins in postmenopausal women. A randomized, double-blind, placebo-controlled, crossover study.
    Haines C; Chung T; Chang A; Masarei J; Tomlinson B; Wong E
    Arch Intern Med; 1996 Apr; 156(8):866-72. PubMed ID: 8774205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined oestrogen-progestogen replacement therapy does not inhibit low-density lipoprotein oxidation in postmenopausal women.
    Wen Y; Doyle MC; Norris LA; Sinnott MM; Cooke T; Harrison RF; Feely J
    Br J Clin Pharmacol; 1999 Mar; 47(3):315-21. PubMed ID: 10218915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of percutaneous oestrogen replacement therapy on Lp(a) and other lipoproteins.
    Haines CJ; Chung TK; Masarei JR; Tomlinson B; Lau JT
    Maturitas; 1995 Nov; 22(3):219-25. PubMed ID: 8746879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.
    Hodis HN; Mack WJ; Lobo RA; Shoupe D; Sevanian A; Mahrer PR; Selzer RH; Liu Cr CR; Liu Ch CH; Azen SP;
    Ann Intern Med; 2001 Dec; 135(11):939-53. PubMed ID: 11730394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipids and antioxidative effects of estradiol and sequential norethisterone acetate treatment in a 3-month randomized controlled trial.
    Falkeborn M; Lithell H; Persson I; Vessby B; Naessén T
    Climacteric; 2002 Sep; 5(3):240-8. PubMed ID: 12419082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hormone replacement therapy on hemostatic cardiovascular risk factors.
    Andersen LF; Gram J; Skouby SO; Jespersen J
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):283-9. PubMed ID: 9988788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of medrogestone on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens: an open randomized comparative study.
    Gevers Leuven JA; van der Mooren MJ; Buytenhek R
    Fertil Steril; 1995 Sep; 64(3):525-31. PubMed ID: 7641905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.
    Imthurn B; Rosselli M; Jaeger AW; Keller PJ; Dubey RK
    J Clin Endocrinol Metab; 1997 Feb; 82(2):388-94. PubMed ID: 9024224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intranasal estradiol treatment on serum lipoprotein(a) and lipids in hysterectomized women.
    Kiran H; Kiran G; Ekerbicer HC; Kilinc M
    Gynecol Obstet Invest; 2004; 57(4):191-5. PubMed ID: 14770012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal cyclic estrogen-progestin therapy lowers lipoprotein[a].
    Mendoza S; Velazquez E; Osona A; Hamer T; Glueck CJ
    J Lab Clin Med; 1994 Jun; 123(6):837-41. PubMed ID: 8201261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.